Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Prof Marella de Bruijn (Professor of Developmental Haematopoiesis), Prof Deborah Gill (Professor of Gene Medicine) and Prof Charalambos Antoniades (Professor of Cardiovascular Medicine) who were all awarded the title of full professor in the recent Recognition of Distinction Exercise.

© Nasir Hamid

This is a huge achievement and reflects not only their research achievements but commitment to teaching and ‘good citizenship’ within the department and beyond.

Prof Marella de Bruijn leads a team investigating the cellular and molecular mechanisms that underlie the generation and maintenance of haemopoietic stem cells (HSCs). Marella is currently Director of Graduate Studies for the department, as well as director of the Doctoral Training Centre.

Prof Deborah Gill co-leads the Gene Medicine Group developing gene therapy for lung conditions, including the genetic disease Cystic Fibrosis (CF). Deborah was previously Director of Graduate Studies for RDM and now acts as Graduate Advisor within the Nuffield Division of Clinical Laboratory Sciences.

Prof Charalambos Antoniades leads a team focusing on the interplay between adipose tissue and cardiovascular disease. He runs a ‘Training in Cardiovascular Research Skills’ course through the British Heart Foundation Centre for Research Excellence.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

COVID-19 patients continue to experience symptoms six months after infection

Study investigating the long-term impact of moderate to severe COVID-19 finds that a large proportion of COVID-19 patients previously admitted to hospital continue to experience intrusive symptoms six months following infection.

RDM researchers awarded Oxford-Bristol Myers Squibb Fellowships

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Six new Oxford-BMS Fellowships for 2021 were announced.